Active Ingredient: ZILEUTON
Proprietary Name: ZILEUTON
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 600MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A215742
Product Number: 001
Approval Date: Oct 11, 2022
Applicant Holder Full Name: ANNORA PHARMA PRIVATE LTD
Marketing Status:
Prescription
Patent and Exclusivity Information